AstraZeneca said on Wednesday its China president Leon Wang had been detained by Chinese authorities and, although it did not ...
AstraZeneca said on Monday its experimental weight-loss pill, licensed from China's Eccogene, was safe and tolerable in an ...
AstraZeneca's price plunge following a fraud investigation in China could be just the time to buy AZN stock as big picture ...
AstraZeneca is scheduled to report results for the third quarter on Tuesday. Here is what to know. CORE EARNINGS PER SHARE: One of the Anglo-Swedish pharmaceutical major's preferred metrics, core EPS ...
In a notice issued to the London Stock Exchange on the company’s share price movement, AstraZeneca (AZN) stated: “As a matter of policy, we do not comment on speculative media reports ...
In this article, we are going to take a look at where AstraZeneca PLC (NASDAQ ... Private sector investment is anticipated to ...
Over the past three years, additional insurance fraud cases have emerged involving AstraZeneca employees in various Chinese regions. The investigation focuses on potential breaches of data privacy ...
AstraZeneca (AZN) said Monday at the ObesityWeek conference in San Antonio, Texas that its experimental obesity pill was well-tolerated by ...
novel small molecule Lipoprotein (a) disruptor that could offer benefits to patients with dyslipidaemia, a disease ...
AstraZeneca disclosed Wednesday that Leon Wang, a high-ranking executive who oversees international operations and is also president of its subsidiary in China, is under investigation by Chinese ...
AstraZeneca Plc said its experimental obesity pill was well tolerated by patients with type-2 diabetes as it presented data from several studies testing its three new weight-loss medicines. The ...
AstraZeneca (AZN) stock falls as a Chinese probe into drug importations and data privacy implicates senior and former ...